(Medical Xpress) -- Working-age adults who take combinations of prescription medication may be doubling their risk of serious falls at home according to research from The University of Auckland.
Jan 23, 2012
0
0
In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance is approximately 400 percent higher than comparable costs paid by the government in the ...
Jan 5, 2012
12
0
Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.
Dec 20, 2011
3
0
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.
Dec 1, 2011
0
0
Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on Wednesday, opening the path to generic competitors for America's most popular medication.
Nov 30, 2011
1
0
(Medical Xpress) -- Toddlers receiving anti-HIV drugs have higher cholesterol levels, on average, than do their peers who do not have HIV, according to researchers at the National Institutes of Health and other institutions.
Nov 22, 2011
0
0
A shot that could lower cholesterol, a connection between blood type and stroke, and how income affects heart health were among more than 4,000 papers presented this week at the American Heart Association's 84th annual scientific ...
Nov 21, 2011
0
0
(Medical Xpress) -- Millions of people take statins, the blockbuster drug that lowers low-density lipoprotein (LDL), the so-called bad cholesterol. But as many as 20 percent of them develop adverse effects such as muscle ...
Nov 18, 2011
1
0
Maximum doses of Crestor (rosuvastatin) or Lipitor (atorvastatin) are similarly effective in reversing the buildup of cholesterol plaques in the coronary artery walls (atherosclerosis) after 24 months of treatment, according ...
Nov 15, 2011
2
0
An operation for preventing repeat strokes in high-risk patients has failed in a multi-institutional clinical trial, scientists report in the Journal of the American Medical Association.
Nov 15, 2011
0
0
